Upneeq Eye Drops
Upneeq is the only FDA-approved prescription eye drop for acquired blepharoptosis (a condition that makes eyes look “tired” or “sleepy”) that lifts upper eyelids to open the eyes. Most patients notice a lift in their eyelids in as little as two hours, and lift improvement is possible with regular use. The solution contains oxymetazoline hydrochloride, which is an alpha adrenoceptor agonist used to treat acquired blepharoptosis in adults. Upneeq is an aseptically prepared, sterile, non-preserved ophthalmic solution.
Upneeq is the only FDA-approved prescription eye drop for acquired blepharoptosis (a condition that makes eyes look “tired” or “sleepy”) that lifts upper eyelids to open the eyes. Most patients notice a lift in their eyelids in as little as two hours, and lift improvement is possible with regular use. The solution contains oxymetazoline hydrochloride, which is an alpha adrenoceptor agonist used to treat acquired blepharoptosis in adults. Upneeq is an aseptically prepared, sterile, non-preserved ophthalmic solution.
Upneeq is the only FDA-approved prescription eye drop for acquired blepharoptosis (a condition that makes eyes look “tired” or “sleepy”) that lifts upper eyelids to open the eyes. Most patients notice a lift in their eyelids in as little as two hours, and lift improvement is possible with regular use. The solution contains oxymetazoline hydrochloride, which is an alpha adrenoceptor agonist used to treat acquired blepharoptosis in adults. Upneeq is an aseptically prepared, sterile, non-preserved ophthalmic solution.